Trial · NCT04531748
Selective Estrogen Modulation and Melatonin in Early COVID-19
NCT04531748, Phase 2, Withdrawn, Reena Mehra, MD
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Selective Estrogen Modulation and Melatonin in Early COVID-19. Trials, record NCT04531748. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04531748
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Selective Estrogen Modulation and Melatonin in Early COVID-19
- NCT number
- NCT04531748
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- Reena Mehra, MD
- Conditions
- Covid19
- Interventions
- Toremifene, Melatonin, Placebo
- First posted
- 2020-08-28
- Last updated
- 2021-05-10
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Peak increase in COVID-19 Sign and Symptom score | Screening to 28 days | Score total of 0-12 assessed daily. Each category based on severity of symptoms of Cough, Shortness of breath, Fatigue/tiredness and daily temperature on a rating scale of 0-3. |
| Secondary | Nadir Oxygen Saturation | Day 1 through day 14 | Daily mean values |
| Secondary | Peak Heart Rate | Day 1 through day 14 | Daily mean values |
| Secondary | Time to COVID-19 Sign and Symptom score resolution | Screening to 28 days | Score total of 0-12 assessed daily. Each category based on severity of symptoms of Cough, Shortness of breath, Fatigue/tiredness and daily temperature on a rating scale of 0-3. |
| Secondary | Time to WHO 7-point ordinal scale score of 3 or higher | Day 1 to Day 30 | 1. not hospitalized, no limitation of activities (or resumption of normal activity) 2. not hospitalized but limitation on activities 3. hospitalized, not requiring supplemental oxygen 4. hospitalized, requiring supplemental oxygen (low-flow, e.g., nasal prong) 5. hospitalized, requiring non-invasive ventilation and/or high-flow oxygen 6. hospitalized, on invasive ventilation or ECMO 7. death |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04531748
GET https://conductscience.org/api/trials/v1/NCT04531748/registered